C3 Jian, Inc. Appoints Vice President, Clinical Operations

LOS ANGELES--(BUSINESS WIRE)--C3 Jian, Inc.’s Board of Directors today announced that Laura A. Navalta has been appointed Vice President of Clinical Operations, effective immediately. Ms. Navalta is the Company’s first senior management hire in the area of clinical and regulatory affairs and brings with her over 25 years of experience in managing products through human clinical trials, from Phase I studies to U.S. Food and Drug Administration (FDA) approval.